Cytodyn Inc (CYDY)

[3X Charm]

Paulson is selling shares at loan shark pricing for management to keep the doors open AND NOT PAY VENDORS, such as Samsung $35m and Amarex at least $6.5m, plus Fife and I am sure others. Please show us the math on the outstanding shares (which have to be around 100m shares) where Paulson gets 13% plus warrants and the market discount is 15% in the last raise. Yes, CYDY can keep the lights on but there is not enough to even pay Samsung even if all remaining shares are sold. Would love to see the calculations.

What is the catalyst here other than the “ the FDA bad, Cydy good.”